29 May 2025 : Clinical Research
Pentraxin 3 as a Prognostic Biomarker in Aneurysmal Subarachnoid Hemorrhage
Dong-Liang Wang ABCD 1, Feng Jiao BCDE 1, Yi-Lin Jiang ABC 1, Hai-Dong Song ABC 1, Bin Li BCD 2, Qun Gao BD 2, Bin Wang DF 2, Bo Hei CDF 2, Jing-Ru Zhou AF 2*DOI: 10.12659/MSM.947133
Med Sci Monit 2025; 31:e947133
Table 4 Univariate analysis of risk factors associated with poor 3-month prognosis.
| Indicators | OR value | 95% CI | P value |
|---|---|---|---|
| WFNS ≥3 | 15.20 | 4.50–51.50 | 0.0009 |
| mFisher ≥3 | 5.81 | 1.95–17.00 | 0.0010 |
| Hunt-Hess ≥3 | 13.00 | 3.95–43.00 | 0.0009 |
| MAP | 1.06 | 0.97–1.12 | 0.045 |
| Acute Hydrocephalus | 3.98 | 1.10–14.00 | 0.040 |
| Pneumonia | 4.25 | 1.47–11.90 | 0.040 |
| PTX3 ≥1.990 | 11.00 | 3.40–35.50 | 0.0010 |
| PTX3 – pentraxin 3; WFNS – World Federation of Neurosurgical Societies; MAP – mean arterial pressure; OR – odds ratio; CI – confidence interval. | |||